The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 27, 2021
Filed:
Dec. 12, 2019
Applicant:
Jazz Pharmaceuticals, Inc., Palo Alto, CA (US);
Inventors:
Clark Allphin, Seattle, WA (US);
James Pfeiffer, Palo Alto, CA (US);
Assignee:
JAZZ PHARMACEUTICALS, INC., Palo Alto, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/19 (2006.01); A61K 9/28 (2006.01); A61K 9/24 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2054 (2013.01); A61K 9/209 (2013.01); A61K 9/284 (2013.01); A61K 9/286 (2013.01); A61K 9/2833 (2013.01); A61K 9/2846 (2013.01); A61K 9/2853 (2013.01); A61K 9/2866 (2013.01); A61K 9/2893 (2013.01); A61K 31/19 (2013.01);
Abstract
Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.